The FDA has approved the use of Vioxx for children suffering from common forms of juvenile rheumatoid arthritis (pauciarticular, polyarticular). The children need to be over 2 years old and weigh more than 22 pounds. Vioxx has already been approved for use in treatment of severe migraine in adults. The approval was based on a study involving 310 patients.
Source: summary of medical news story as reported by News Target Network
About: Vioxx approved for treatment of juvenile rheumatoid arthritis
Date: 7 December 2004
Source: News Target Network
URL:
http:/ This summary article refers to the following medical categories:
What do you think about the features of this website?
Take our user survey and have your say:
Tools & Services:
Medical Articles:
Related Medical Topics
» Next page: Vioxx costing Merck millions
Rate This Website
Medical Tools & Articles:
Forums & Message Boards
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
